PT1392670E - Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina - Google Patents
Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilaminaInfo
- Publication number
- PT1392670E PT1392670E PT02743057T PT02743057T PT1392670E PT 1392670 E PT1392670 E PT 1392670E PT 02743057 T PT02743057 T PT 02743057T PT 02743057 T PT02743057 T PT 02743057T PT 1392670 E PT1392670 E PT 1392670E
- Authority
- PT
- Portugal
- Prior art keywords
- methylamine
- thiofen
- furan
- substituted derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10125145A DE10125145A1 (de) | 2001-05-22 | 2001-05-22 | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1392670E true PT1392670E (pt) | 2005-10-31 |
Family
ID=7685874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02743057T PT1392670E (pt) | 2001-05-22 | 2002-05-21 | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6878740B2 (pt) |
| EP (1) | EP1392670B1 (pt) |
| JP (1) | JP2004532246A (pt) |
| AR (1) | AR035982A1 (pt) |
| AT (1) | ATE299873T1 (pt) |
| AU (1) | AU2002338989B2 (pt) |
| CA (1) | CA2448038C (pt) |
| DE (2) | DE10125145A1 (pt) |
| DK (1) | DK1392670T3 (pt) |
| ES (1) | ES2242869T3 (pt) |
| HU (1) | HUP0401162A3 (pt) |
| MX (1) | MXPA03010601A (pt) |
| PE (1) | PE20021099A1 (pt) |
| PL (1) | PL367535A1 (pt) |
| PT (1) | PT1392670E (pt) |
| SI (1) | SI1392670T1 (pt) |
| WO (1) | WO2002094802A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302094D0 (en) * | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| KR100553398B1 (ko) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
| BR112012000254A2 (pt) | 2009-07-08 | 2016-02-16 | Dermira Canada Inc | análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas. |
| AU2014352793B2 (en) * | 2013-11-22 | 2019-05-09 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
| WO2017209322A1 (ko) * | 2016-05-31 | 2017-12-07 | 한림대학교 산학협력단 | 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| CN112521357B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3890445A (en) * | 1973-01-05 | 1975-06-17 | Richardson Merrell Inc | Lactamimide derivatives useful as hypoglycemic agents |
| US3816457A (en) * | 1973-01-05 | 1974-06-11 | Richardson Merrell Inc | Lactamimide derivatives |
| WO2001068816A1 (en) | 2000-03-13 | 2001-09-20 | Smithkline Beecham Corporation | Human histamine h3 gene variant-3 |
| DE10012820A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine |
| DE10059864A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
-
2001
- 2001-05-22 DE DE10125145A patent/DE10125145A1/de not_active Withdrawn
-
2002
- 2002-05-17 AR ARP020101843A patent/AR035982A1/es not_active Application Discontinuation
- 2002-05-21 EP EP02743057A patent/EP1392670B1/de not_active Expired - Lifetime
- 2002-05-21 AU AU2002338989A patent/AU2002338989B2/en not_active Ceased
- 2002-05-21 PL PL02367535A patent/PL367535A1/xx not_active Application Discontinuation
- 2002-05-21 CA CA2448038A patent/CA2448038C/en not_active Expired - Fee Related
- 2002-05-21 JP JP2002591475A patent/JP2004532246A/ja active Pending
- 2002-05-21 PE PE2002000428A patent/PE20021099A1/es not_active Application Discontinuation
- 2002-05-21 DE DE50203686T patent/DE50203686D1/de not_active Expired - Lifetime
- 2002-05-21 AT AT02743057T patent/ATE299873T1/de not_active IP Right Cessation
- 2002-05-21 MX MXPA03010601A patent/MXPA03010601A/es active IP Right Grant
- 2002-05-21 HU HU0401162A patent/HUP0401162A3/hu unknown
- 2002-05-21 ES ES02743057T patent/ES2242869T3/es not_active Expired - Lifetime
- 2002-05-21 WO PCT/EP2002/005542 patent/WO2002094802A1/de active IP Right Grant
- 2002-05-21 PT PT02743057T patent/PT1392670E/pt unknown
- 2002-05-21 DK DK02743057T patent/DK1392670T3/da active
- 2002-05-21 SI SI200230178T patent/SI1392670T1/sl unknown
-
2003
- 2003-11-21 US US10/717,932 patent/US6878740B2/en not_active Expired - Fee Related
-
2005
- 2005-03-07 US US11/072,962 patent/US7317034B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK1392670T3 (da) | 2005-08-08 |
| US20040152734A1 (en) | 2004-08-05 |
| SI1392670T1 (sl) | 2005-12-31 |
| US7317034B2 (en) | 2008-01-08 |
| HUP0401162A3 (en) | 2007-05-02 |
| EP1392670B1 (de) | 2005-07-20 |
| US6878740B2 (en) | 2005-04-12 |
| AU2002338989B2 (en) | 2007-06-07 |
| DE10125145A1 (de) | 2002-11-28 |
| PE20021099A1 (es) | 2003-01-25 |
| MXPA03010601A (es) | 2004-03-09 |
| DE50203686D1 (en) | 2005-08-25 |
| US20050148550A1 (en) | 2005-07-07 |
| ATE299873T1 (de) | 2005-08-15 |
| AR035982A1 (es) | 2004-07-28 |
| CA2448038C (en) | 2010-09-28 |
| HUP0401162A2 (hu) | 2004-10-28 |
| CA2448038A1 (en) | 2002-11-28 |
| WO2002094802A1 (de) | 2002-11-28 |
| EP1392670A1 (de) | 2004-03-03 |
| JP2004532246A (ja) | 2004-10-21 |
| ES2242869T3 (es) | 2005-11-16 |
| PL367535A1 (en) | 2005-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR20C1039I2 (fr) | Derives de l'uk-2a | |
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| NO20041975D0 (no) | Bicyklisk oksopyridin og oksopyrimidinderivater | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| PT1406628E (pt) | Derivados de tera-hidroquinolina | |
| ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
| NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
| FR2830516B1 (fr) | Suspension de turboreacteur | |
| ID30187A (id) | Dongkrak jenis pantagraf | |
| BRPI0208558A2 (pt) | preparado de combinação de estrogênio-gestagênio e uso | |
| AR028281A1 (es) | Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona | |
| FI20010558A (fi) | Kappaleiden paikannus | |
| EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
| NO20041968L (no) | Anvendelse av cystationin | |
| DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
| PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
| PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
| ATE382601T1 (de) | Substituierte 4-aminocyclohexanolderivate | |
| DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| DE60202381D1 (de) | Paroxetin-n-formyl-derivate | |
| ATE331956T1 (de) | Nachweis von entzündungen | |
| DE50209548D1 (de) | Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen | |
| DE60219418T8 (de) | Silanylphenole und -naphthole | |
| PT1232141E (pt) | Eteres de o-desmetil-venlafaxina |